We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential.
- Authors
Hai Yong Chen; Huang, Xiao R.; Wansheng Wang; Jin Hua Li; Heuchel, Rainer L.; Chung, Arthur C. K.; Hui Yao Lan
- Abstract
OBJECTIVE--Although Smad3 has been considered as a downstream mediator of transforming growth factor-β (TGF-β) signaling in diabetes complications, the role of Smad7 in diabetes remains largely unclear. The current study tests the hypothesis that Smad7 may play a protective role and has therapeutic potential for diabetic kidney disease. RESEARCH DESIGN AND METHODS--Protective role of Smad7 in diabetic kidney disease was examined in streptozotocin-induced diabetic mice that have Smad7 gene knockout (KO) and in diabetic rats given Smad7 gene transfer using an ultrasound-microbubble-mediated technique. RESULTS--We found that mice deficient for Smad7 developed more severe diabetic kidney injury than wild-type mice as evidenced by a significant increase in microalbuminuria, renal fibrosis (collagen I, IV, and fibronectin), and renal inflammation (interleukin-1β [IL-1β], tumor necrosis factor-a [TNF-α], monocyte chemoattractant protein-1 [MCP-1], intracellular adhesion molecule-1 [ICAM-1], and macrophages). Further studies revealed that enhanced renal fibrosis and inflammation in Smad7 KO mice with diabetes were associated with increased activation of both TGF-β/Smad2/3 and nuclear factor-κB (NF-κB) signaling pathways. To develop a therapeutic potential for diabetic kidney disease, Smad7 gene was transferred into the kidney in diabetic rats by an ultrasound-microbubble-mediated technique. Although overexpression of renal Smad7 had no effect on levels of blood glucose, it significantly attenuated the development of microalbuminuria, TGF-β/Smad3-mediated renal fibrosis such as collagen I and IV and fibronectin accumulation and NF-κB/ p65-driven renal inflammation including IL-1β, TNF-α, MCP-1, and ICAM-1 expression and macrophage infiltration in diabetic rats. CONCLUSIONS--Smad7 plays a protective role in diabetic renal injury. Overexpression of Smad7 may represent a novel therapy for the diabetic kidney complication.
- Subjects
TRANSFORMING growth factors-beta; DIABETES complications; KIDNEY diseases; STREPTOZOTOCIN; LABORATORY mice; GENETIC transformation; FIBROSIS; NF-kappa B
- Publication
Diabetes, 2011, Vol 60, Issue 2, p590
- ISSN
0012-1797
- Publication type
Article
- DOI
10.2337/db10-0403